Australia Is Reviewing Amadeus's $1.2 Billion Biometric Border Deal
Australia's competition regulator is assessing Amadeus's 1.2 billion euro purchase of Idemia Public Security. Both companies supply biometric systems to border control.

A Border Control Deal Under the Microscope
Australia's competition regulator is now formally assessing Amadeus's 1.2 billion euro purchase of Idemia Public Security, and the case is a useful window into how merger control works when the product is something most travelers never think about. The Australian Competition and Consumer Commission lists the deal on its public acquisitions register as case MN-60027, with an effective notification date of November 11, 2026. It is in Phase 1, the initial stage for every notified deal, and third parties have until November 19 to answer the regulator's questionnaire.
The deal itself was announced on April 29, 2026. Amadeus IT Group, the Spanish travel technology company behind much of the world's airline booking infrastructure, proposes to acquire 100 percent of the shares in Idemia Public Security France SAS and Idemia Government USA Corp. and their subsidiaries. The price is 1.2 billion euros, with an earn-out that could take the total to 1.35 billion. Closing is subject to customary regulatory approvals and is expected in mid-2027.
The reason Australia cares is specific. Both Amadeus and Idemia Public Security supply front-end biometric border control systems to the Department of Home Affairs, the agency that runs Australia's borders. When two suppliers of the same critical system propose to become one, the regulator has to ask whether airports and the government will still have a genuine choice of vendor, and whether prices and service quality will suffer if they do not.
How the Amadeus Idemia Deal Review Works
The ACCC has published no view on the deal yet, which is normal at this stage. Phase 1 runs up to 30 business days unless extended, and the register lists January 11, 2027 as the end of the determination period. The regulator's guidance says most acquisitions are expected to be approved in Phase 1, no earlier than business day 15, and that a small number need a Phase 2 assessment of up to 90 further business days. The questionnaire now open to third parties is how the ACCC gathers evidence from the people who would actually feel the effects: airlines, airports, government buyers, and rival suppliers.
The deal has already cleared one hurdle. Taiwan's Fair Trade Commission resolved at its meeting on October 7, 2026 not to prohibit the combination. That is one jurisdiction down, but merger review is not a single global decision. Each regulator examines the competitive effects inside its own market, and Australia's concern is specifically about biometric border systems supplied to Home Affairs, a market where the two companies overlap directly.
Why Biometric Borders Are a Competition Issue
Biometric border systems are the gates, kiosks, and software that match your face or fingerprint to your passport when you enter a country. They are a small market by revenue but a critical one by function: if the systems fail, queues build, flights delay, and border security weakens. Governments buy these systems in long contracts with high switching costs, because replacing the hardware at every airport gate is expensive and disruptive. That makes the number of credible suppliers matter more than in a typical software market. Lose one, and the buyer has little leverage left.
Amadeus's interest in the deal is easy to see. The company already sells the software that airlines use to manage bookings, check-in, and departures. Owning the biometric layer at the border extends its reach from the booking to the gate, and gives it a fuller picture of the passenger journey. For Idemia, the deal offers scale and a parent company with deep travel industry relationships. For regulators, the question is whether that vertical logic comes at the cost of competition in the biometric layer itself.
The Amadeus review sits in a busy season for merger watchers. The European Commission conditionally approved JD.com's 2.2 billion euro acquisition of Ceconomy on November 3, after accepting ten-year behavioral commitments, a deal we covered in our JD.com Ceconomy takeover article. And the US Justice Department has signaled openness to behavioral remedies in merger cases, a shift that could change how big deals get cleared. The pattern across all three is that regulators are increasingly willing to approve deals with conditions attached, rather than blocking them outright or demanding asset sales.
For Amadeus, the next milestone is January 11, 2027, when the ACCC's Phase 1 determination period ends. If the regulator clears the deal, closing can proceed toward the mid-2027 target. If it has concerns, the review moves to Phase 2, and the timeline stretches. Either way, the case is worth watching as a test of how seriously regulators take competition in the infrastructure travelers never see. For more on the deals reshaping big tech this month, see our coverage of the Anthropic IPO roadshow and Amazon's $5 billion data center sale to Blackstone.


